source
- The R&D 15: How pharma's top companies spent, won and lost on drug researchTalking over pharma pipelines with a major drugmaker's development chief, he noted that if you looked at the biggest 50 drugs by revenue, the final one on the list brought in about $4 billion last ...
- Pfizer reports positive Phase 3 results for Elrexfio in relapsed multiple myelomaPfizer announced that its antibody-drug conjugate Elrexfio achieved a statistically significant and clinically meaningful improvement in progression-free survival for patients with relapsed or refr…